Cargando…
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1
The identification of universal tumor-specific antigens shared between multiple patients and/or multiple tumors is of great importance to overcome the practical limitations of personalized cancer immunotherapy. Recent studies support the involvement of DEPDC1 in many aspects of cancer traits, such a...
Autores principales: | Tosi, Anna, Dalla Santa, Silvia, Cappuzzello, Elisa, Marotta, Carolina, Walerich, Dawid, Del Sal, Giannino, Zanovello, Paola, Sommaggio, Roberta, Rosato, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593712/ https://www.ncbi.nlm.nih.gov/pubmed/28919988 http://dx.doi.org/10.1080/2162402X.2017.1313371 |
Ejemplares similares
-
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies
por: Cappuzzello, Elisa, et al.
Publicado: (2016) -
HLA-A*0201-restricted CD8(+) T-cell epitopes identified in dengue viruses
por: Duan, Zhi-Liang, et al.
Publicado: (2012) -
Identification of Novel HLA-A*0201-Restricted CTL Epitopes in Chinese Vitiligo Patients
por: Cui, Tingting, et al.
Publicado: (2016) -
Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from neuritin
por: Yang, Zhao, et al.
Publicado: (2013) -
Prediction and identification of novel HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from endocan
por: Shao, Gaohai, et al.
Publicado: (2020)